Walleye Capital’s LifeVantage LFVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-24,285
Closed -$105K 4991
2026
Q1
$105K Sell
24,285
-22,608
-48% -$118K ﹤0.01% 3652
2025
Q4
$289K Buy
+46,893
New +$347K ﹤0.01% 3343
2023
Q4
Sell
-20,069
Closed -$129K 5251
2023
Q3
$129K Buy
+20,069
New +$112K ﹤0.01% 3810
2022
Q1
Sell
-15,508
Closed -$98K 2443
2021
Q4
$98K Sell
15,508
-5,335
-26% -$36.3K ﹤0.01% 1693
2021
Q3
$141K Buy
20,843
+1,064
+5% +$7.83K ﹤0.01% 1260
2021
Q2
$145K Buy
19,779
+2,346
+13% +$19.2K ﹤0.01% 1118
2021
Q1
$163K Buy
17,433
+2,533
+17% +$23.6K 0.01% 958
2020
Q4
$139K Buy
+14,900
New +$167K 0.01% 779

Other funds holding LFVN

Walleye Capital's LFVN Position: Q2 2026 in Review

Walleye Capital sold out of LifeVantage (LFVN) in Q2 2026, closing a stake of 24,285 shares — an estimated $105K sold.

Walleye Capital first reported a position in LFVN in Q4 2020 and held it in 8 quarters. The position peaked at $289K in Q4 2025. 88 funds tracked by Wall St. Rank hold LFVN as of Q2 2026.

  • Walleye Capital reported no remaining LifeVantage position as of Q2 2026 after selling out during the quarter.
  • Walleye Capital sold 24,285 LifeVantage shares in Q2 2026, an estimated $105K.
  • Walleye Capital first reported a position in LifeVantage in Q4 2020 and held it in 8 quarters.
  • Walleye Capital's LifeVantage position peaked at $289K in Q4 2025.
  • 88 funds tracked by Wall St. Rank held LifeVantage as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.